Starting from:

$17150

Tardive Dyskinesia (U.S.), January 2024

MarketVue®: Tardive Dyskinesia (TD)


The MarketVue®: Tardive Dyskinesia (TD) market landscape report combines primary (KOL interviews and survey data) and secondary market research to empower strategic decision-making and provide a complete view of the market.

Every MarketVue® includes a disease overview, epidemiology (US and EU5), current treatment, unmet needs, pipeline and access and reimbursement chapter.